.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Harvard Business School
Merck
Medtronic
Daiichi Sankyo
Fuji
McKinsey
QuintilesIMS
Dow
Healthtrust

Generated: November 21, 2017

DrugPatentWatch Database Preview

Institut Biochimique Company Profile

« Back to Dashboard

What is the competitive landscape for INSTITUT BIOCHIMIQUE, and what generic alternatives to INSTITUT BIOCHIMIQUE drugs are available?

INSTITUT BIOCHIMIQUE has three approved drugs.

There are two US patents protecting INSTITUT BIOCHIMIQUE drugs.

There are sixteen patent family members on INSTITUT BIOCHIMIQUE drugs in nine countries.

Summary for Institut Biochimique

International Patents:16
US Patents:2
Tradenames:2
Ingredients:1
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Institut Biochimique
TIROSINT
levothyroxine sodium
CAPSULE;ORAL021924-011Apr 25, 2017RXYesNo► Subscribe► Subscribe► Subscribe
Institut Biochimique
TIROSINT-SOL
levothyroxine sodium
SOLUTION;ORAL206977-009Dec 15, 2016DISCNYesNo► Subscribe► Subscribe► Subscribe
Institut Biochimique
TIROSINT-SOL
levothyroxine sodium
SOLUTION;ORAL206977-012Dec 15, 2016DISCNYesNo► Subscribe► Subscribe► Subscribe
Institut Biochimique
TIROSINT
levothyroxine sodium
CAPSULE;ORAL021924-004Oct 13, 2006RXYesNo► Subscribe► SubscribeY ► Subscribe
Institut Biochimique
TIROSINT
levothyroxine sodium
CAPSULE;ORAL022121-001Aug 1, 2007RXNoNo► Subscribe► SubscribeY ► Subscribe
Institut Biochimique
TIROSINT-SOL
levothyroxine sodium
SOLUTION;ORAL206977-010Dec 15, 2016DISCNYesNo► Subscribe► Subscribe► Subscribe
Institut Biochimique
TIROSINT
levothyroxine sodium
CAPSULE;ORAL021924-010Oct 2, 2009RXYesNo► Subscribe► SubscribeY ► Subscribe
Institut Biochimique
TIROSINT
levothyroxine sodium
CAPSULE;ORAL021924-009Oct 2, 2009RXYesNo► Subscribe► SubscribeY ► Subscribe
Institut Biochimique
TIROSINT-SOL
levothyroxine sodium
SOLUTION;ORAL206977-007Dec 15, 2016DISCNYesNo► Subscribe► Subscribe► Subscribe
Institut Biochimique
TIROSINT-SOL
levothyroxine sodium
SOLUTION;ORAL206977-003Dec 15, 2016DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Institut Biochimique Drugs

Country Document Number Estimated Expiration
Spain2254559► Subscribe
Germany60329968► Subscribe
Japan2004210780► Subscribe
Canada2454050► Subscribe
Denmark1291021► Subscribe
Germany60207951► Subscribe
Austria312621► Subscribe
Japan5105685► Subscribe
Austria447939► Subscribe
Japan2003081870► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
UBS
Dow
Citi
Mallinckrodt
Fish and Richardson
Cantor Fitzgerald
Novartis
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot